Mercer Global Advisors’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.15M Buy
164,660
+46,322
+39% +$1.17M 0.01% 967
2026
Q1
$2.99M Buy
118,338
+23,870
+25% +$609K ﹤0.01% 1004
2025
Q4
$2.41M Buy
94,468
+24,130
+34% +$618K ﹤0.01% 1019
2025
Q3
$1.8M Buy
70,338
+14,355
+26% +$364K ﹤0.01% 1080
2025
Q2
$1.42M Buy
55,983
+5,050
+10% +$125K ﹤0.01% 1041
2025
Q1
$1.27M Buy
50,933
+10,314
+25% +$255K ﹤0.01% 1014
2024
Q4
$998K Buy
40,619
+19,300
+91% +$483K ﹤0.01% 1118
2024
Q3
$548K Buy
21,319
+10,167
+91% +$257K ﹤0.01% 1299
2024
Q2
$274K Buy
+11,152
New +$272K ﹤0.01% 1623

Other funds holding IBDX

Mercer Global Advisors's IBDX Position: Q2 2026 in Review

Mercer Global Advisors increased its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 39% in Q2 2026, buying an estimated $1.17M and bringing the position to 164,660 shares worth $4.15M. The position accounts for 0.01% of the portfolio, ranked #967.

Mercer Global Advisors first reported a position in IBDX in Q2 2024 and has held it in 9 quarters since. 228 funds tracked by Wall St. Rank hold IBDX as of Q2 2026.

  • Mercer Global Advisors held 164,660 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $4.15M as of Q2 2026.
  • Mercer Global Advisors bought 46,322 iShares iBonds Dec 2032 Term Corporate ETF shares in Q2 2026, an estimated $1.17M.
  • iShares iBonds Dec 2032 Term Corporate ETF made up 0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #967 holding.
  • Mercer Global Advisors first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q2 2024 and has held it in 9 quarters since.
  • 228 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.